Singapore Eye Research Institute's Roger Beuerman wants to bring point-of-care eye diagnostics to the ophthalmologist's office.
The device, which will be tested in collaboration with a Panamanian research institute, will run 40-minute tests without the need for electricity.
The point-of-care test detects and distinguishes influenza A and B as well as respiratory syncytial virus in about 20 minutes.
Abbott's MDx sales were driven by continued strong growth in its infectious disease testing business but were partly offset by the planned scale down of its genetics business.
The firm postponed the launch to enhance Omni's capabilities, in the meantime focusing on opportunities in near-patient testing for its GeneXpert system.
QuantuMDx says its low-cost, handheld device will be able to quickly diagnose patients, as the Guardian reports.
Abbott reported Diagnostics sales of $1.12 billion, up 2 percent on a reported basis and 7 percent excluding foreign currency effects.
The company will use the funding to prepare for the 2017 launch of its DiagCore integrated molecular and immunoassay near-patient testing platform.
The partners will develop a new product using MBio's multiplex, point-of-care testing system and Roka's experience in food safety testing.
The partners are broadening their collaboration to bring point-of-care TB diagnostics to all levels of the health system in low- and middle-income countries.
In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.
Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.
Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.
The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.